EA201791346A1 - ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ - Google Patents
ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕInfo
- Publication number
- EA201791346A1 EA201791346A1 EA201791346A EA201791346A EA201791346A1 EA 201791346 A1 EA201791346 A1 EA 201791346A1 EA 201791346 A EA201791346 A EA 201791346A EA 201791346 A EA201791346 A EA 201791346A EA 201791346 A1 EA201791346 A1 EA 201791346A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- benzo
- phenyl
- amino
- yhychen
- ichychd
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
В настоящей заявке предложены композиции, включающие кристаллические формы (1E,4E)-2-амино-N,N-дипропил-8-(4-(пирролидин-1-карбонил)фенил)-3Н-бензо[b]азепин-4-карбоксамида ("соединения А"), способы получения кристаллических форм и способы применения кристаллических форм для лечения заболеваний, в том числе, например, рака.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462092764P | 2014-12-16 | 2014-12-16 | |
PCT/US2015/065755 WO2016100302A2 (en) | 2014-12-16 | 2015-12-15 | Solid forms comprising (1e, 4e)-2-amino-n,n-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3h-benzo[b]azepine-4-carboxamide, compositions thereof, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791346A1 true EA201791346A1 (ru) | 2018-01-31 |
Family
ID=56127832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791346A EA201791346A1 (ru) | 2014-12-16 | 2015-12-15 | ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ |
Country Status (12)
Country | Link |
---|---|
US (2) | US20190100512A1 (ru) |
EP (1) | EP3233088A4 (ru) |
JP (2) | JP6707088B2 (ru) |
KR (1) | KR20170118700A (ru) |
AU (1) | AU2015362720B2 (ru) |
BR (1) | BR112017012646A2 (ru) |
CA (1) | CA2970358A1 (ru) |
EA (1) | EA201791346A1 (ru) |
IL (1) | IL252744A0 (ru) |
MX (1) | MX2017007955A (ru) |
SG (1) | SG11201704791WA (ru) |
WO (1) | WO2016100302A2 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015362720B2 (en) | 2014-12-16 | 2019-11-21 | Celgene Corporation | Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo(b)azepine-4-carboxamide, compositions thereof, and uses thereof |
CA3055652A1 (en) | 2017-03-15 | 2018-09-20 | Silverback Therapeutics, Inc. | Benzazepine compounds, conjugates, and uses thereof |
CN109320456A (zh) * | 2018-11-16 | 2019-02-12 | 天津商业大学 | 新晶型的抗肿瘤化合物及其制备方法和含其的组合物 |
WO2021168274A1 (en) | 2020-02-21 | 2021-08-26 | Silverback Therapeutics, Inc. | Nectin-4 antibody conjugates and uses thereof |
JP2023532304A (ja) | 2020-07-01 | 2023-07-27 | エーアールエス ファーマシューティカルズ オペレーションズ,インク. | 抗asgr1抗体コンジュゲートおよびその使用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US20020048610A1 (en) | 2000-01-07 | 2002-04-25 | Cima Michael J. | High-throughput formation, identification, and analysis of diverse solid-forms |
TW201402124A (zh) * | 2005-08-19 | 2014-01-16 | Array Biopharma Inc | 作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯 |
DK2313111T3 (da) * | 2008-08-01 | 2013-12-02 | Ventirx Pharmaceuticals Inc | Toll-lignende receptoragonistformuleringer og anvendelse deraf |
EP2940009B1 (en) | 2008-11-06 | 2018-10-17 | VentiRx Pharmaceuticals, Inc. | Methods of synthesis of benzazepine derivatives |
US20120082658A1 (en) * | 2010-10-01 | 2012-04-05 | Ventirx Pharmaceuticals, Inc. | Methods for the Treatment of Allergic Diseases |
AU2015362720B2 (en) | 2014-12-16 | 2019-11-21 | Celgene Corporation | Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo(b)azepine-4-carboxamide, compositions thereof, and uses thereof |
-
2015
- 2015-12-15 AU AU2015362720A patent/AU2015362720B2/en not_active Ceased
- 2015-12-15 JP JP2017532617A patent/JP6707088B2/ja not_active Expired - Fee Related
- 2015-12-15 EP EP15870852.9A patent/EP3233088A4/en not_active Withdrawn
- 2015-12-15 BR BR112017012646-0A patent/BR112017012646A2/pt not_active Application Discontinuation
- 2015-12-15 CA CA2970358A patent/CA2970358A1/en not_active Abandoned
- 2015-12-15 EA EA201791346A patent/EA201791346A1/ru unknown
- 2015-12-15 WO PCT/US2015/065755 patent/WO2016100302A2/en active Application Filing
- 2015-12-15 SG SG11201704791WA patent/SG11201704791WA/en unknown
- 2015-12-15 US US15/537,331 patent/US20190100512A1/en not_active Abandoned
- 2015-12-15 KR KR1020177019310A patent/KR20170118700A/ko unknown
- 2015-12-15 MX MX2017007955A patent/MX2017007955A/es active IP Right Grant
-
2017
- 2017-06-07 IL IL252744A patent/IL252744A0/en unknown
-
2019
- 2019-09-13 US US16/570,191 patent/US10604510B2/en not_active Expired - Fee Related
-
2020
- 2020-01-31 JP JP2020014267A patent/JP2020079261A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200002316A1 (en) | 2020-01-02 |
US20190100512A1 (en) | 2019-04-04 |
IL252744A0 (en) | 2017-08-31 |
JP6707088B2 (ja) | 2020-06-10 |
MX2017007955A (es) | 2018-02-19 |
KR20170118700A (ko) | 2017-10-25 |
AU2015362720A1 (en) | 2017-07-06 |
WO2016100302A2 (en) | 2016-06-23 |
CA2970358A1 (en) | 2016-06-23 |
SG11201704791WA (en) | 2017-07-28 |
US10604510B2 (en) | 2020-03-31 |
JP2017537962A (ja) | 2017-12-21 |
EP3233088A4 (en) | 2018-09-19 |
WO2016100302A3 (en) | 2016-09-15 |
JP2020079261A (ja) | 2020-05-28 |
BR112017012646A2 (pt) | 2018-01-02 |
EP3233088A2 (en) | 2017-10-25 |
AU2015362720B2 (en) | 2019-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
EA201791002A1 (ru) | Новые соединения, модулирующие fxr (nr1h4) | |
EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
EA201791256A1 (ru) | Производные хиназолина, применяемые для лечения вич | |
EA201790078A1 (ru) | Ингибиторы mnk и связанные с ними способы | |
EA201692079A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
EA201691857A1 (ru) | Соединения, применимые в качестве иммуномодуляторов | |
EA201991884A2 (ru) | Ингибиторы g12c kras | |
PH12016502378A1 (en) | Substituted dihydroisoquinolinone compounds | |
EA201692261A1 (ru) | Гетероарильные соединения для ингибирования киназ | |
EA202090486A2 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201692203A1 (ru) | Соединения, ингибирующие tank-связывающую киназу | |
EA201791305A1 (ru) | Конденсированные пиримидины для лечения вич | |
EA201691803A1 (ru) | Ингибиторы калликреина плазмы человека | |
EA201400412A1 (ru) | ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ | |
EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
EA201501142A1 (ru) | Гетероциклические соединения в качестве средств для борьбы с вредителями | |
EA201790892A1 (ru) | Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]}пиримидин-2,4-диамина | |
EA201790395A1 (ru) | Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы | |
EA201492040A1 (ru) | Бициклически замещённые урацилы и их применение | |
EA201690371A1 (ru) | Пиридазиноновые соединения и их применение | |
EA201692003A1 (ru) | Макроциклические производные пиримидина | |
EA201791346A1 (ru) | ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ | |
EA201791096A1 (ru) | 4-оксо-3,4-дигидро-1,2,3-бензотриазины в качестве модуляторов gpr139 |